Safety, blood levels and effects of GSK2269557 in smokers (v1)

• Research type

  Research Study

• Full title

  A single-centre, double-blind, placebo controlled two part study to evaluate the safety, tolerability and pharmacokinetics of single and repeat doses of GSK2269557 as a dry powder in healthy subjects who smoke cigarettes (HMR code: 12-026).

• IRAS ID

  118583

• Contact name

  Malcolm Boyce

• Contact email

  vparker@hmrlondon.com

• Sponsor organisation

  GlaxoSmithKline

• Eudract number

  2012-004262-17

• REC name

  London - Brent Research Ethics Committee

• REC reference

  12/LO/1820

• Date of REC Opinion

  4 Dec 2012

• REC opinion

  Favourable Opinion